134 related articles for article (PubMed ID: 17855179)
1. The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials.
Hu JK; Li CM; Chen XZ; Chen ZX; Zhou ZG; Zhang B; Chen JP
J Chemother; 2007 Aug; 19(4):359-75. PubMed ID: 17855179
[TBL] [Abstract][Full Text] [Related]
2. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
Chang HM; Jung KH; Kim TY; Kim WS; Yang HK; Lee KU; Choe KJ; Heo DS; Bang YJ; Kim NK
Ann Oncol; 2002 Nov; 13(11):1779-85. PubMed ID: 12419751
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of precautionary chemotherapy in gastric cancer].
Rimassa L; Campagnoli E; Biancofiore G
Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
5. Gastric carcinoma: curative resection and adjuvant chemotherapy.
Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
[TBL] [Abstract][Full Text] [Related]
6. Review of adjuvant chemotherapy for gastric cancer.
Nakajima T
World J Surg; 1995; 19(4):570-4. PubMed ID: 7676702
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S;
J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
[TBL] [Abstract][Full Text] [Related]
9. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for advanced gastric cancer.
Wagner AD; Grothe W; Behl S; Kleber G; Grothey A; Haerting J; Fleig WE
Cochrane Database Syst Rev; 2005 Apr; (2):CD004064. PubMed ID: 15846694
[TBL] [Abstract][Full Text] [Related]
11. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.
Oechsle K; Bokemeyer C; Hartmann JT; Budach W; Trarbach T; Stahl M; Boehlke I; Kollmannsberger C;
J Cancer Res Clin Oncol; 2009 Feb; 135(2):163-72. PubMed ID: 18825411
[TBL] [Abstract][Full Text] [Related]
12. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.
Hu JK; Chen ZX; Zhou ZG; Zhang B; Tian J; Chen JP; Wang L; Wang CH; Chen HY; Li YP
World J Gastroenterol; 2002 Dec; 8(6):1023-8. PubMed ID: 12439918
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Atiq OT; Kelsen DP; Shiu MH; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M
J Clin Oncol; 1993 Mar; 11(3):425-33. PubMed ID: 8445416
[TBL] [Abstract][Full Text] [Related]
14. Advances in the therapy of gastric cancer.
Macdonald JS
Gastric Cancer; 2002; 5 Suppl 1():35-40. PubMed ID: 12772886
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.
Zhang YW; Zhang YL; Pan H; Wei FX; Zhang YC; Shao Y; Han W; Liu HP; Wang ZY; Yang SH
World J Gastroenterol; 2014 Jan; 20(2):584-92. PubMed ID: 24574729
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
17. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
[TBL] [Abstract][Full Text] [Related]
19. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
Wilke H; Stahl M; Vanhoefer U
MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up.
Neri B; Cini G; Andreoli F; Boffi B; Francesconi D; Mazzanti R; Medi F; Mercatelli A; Romano S; Siliani L; Tarquini R; Moretti R
Br J Cancer; 2001 Apr; 84(7):878-80. PubMed ID: 11286464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
